ArticleBMC musculoskeletal disorders2019
Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients.
Article in BMC musculoskeletal disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.
- A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.Current oncology (Toronto, Ont.) · 2024Pooled it
- Thumb Distal Phalanx Enchondroma: Expanding the Surgical Corridor Through a Modified Volar Lateral Technique - A Case Report.Journal of orthopaedic case reports · 2026Article
- Wait, scan and then? Exploring the long-term natural course of 119 low-grade central cartilaginous lesions of the long bones with MRI follow-up.European radiology · 2026Article
- Diagnostic Dilemma in a Distal Femoral Intramedullary Lesion: Enchondroma Mimicking Low-Grade Chondrosarcoma with Discordant Biopsy Findings: A Case Report.Journal of orthopaedic case reports · 2026Article
- Imaging findings and complications after curettage of atypical cartilaginous tumors in long bones: a retrospective single-center cohort study.Skeletal radiology · 2026Article
- Differential diagnosis and management of subaxial cervical chondroma: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- Article
- Deep learning for automated segmentation of central cartilage tumors on MRI.European radiology experimental · 2025Article
- A comprehensive deep learning approach to improve enchondroma detection on X-ray images.Scientific reports · 2025Article
- Long-term Follow-up Study for Fractured and Non-Fractured Hand Enchondromas Treated by Sole Curettage.Archives of plastic surgery · 2025Article
- Fixation with Carbon Fiber Plates After Curettage in Benign and Locally Aggressive Bone Tumors: Clinical and Radiographic Outcomes.Journal of clinical medicine · 2025Article
- A Rare Case of Low-Grade Bilateral Proximal Humerus Chondrosarcomas Managed With Staged Curettage and Cementation.Cureus · 2025Article
- UK guidelines for the management of bone sarcomas.British journal of cancer · 2025Review
- Clinical outcome of curettage in atypical cartilaginous tumors of the long bones: a descriptive cohort study.Acta orthopaedica · 2024Article
- Spinal Enchondromas in the Cervical Spine: Rarity, Recurrence and the Importance of Long-Term Surveillance.Journal of orthopaedic case reports · 2024Article
- Preoperative prediction of histopathological grading in patients with chondrosarcoma using MRI-based radiomics with semantic features.BMC medical imaging · 2024Article
- Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations.Journal of bone oncology · 2023Article
- Fracture risk after intralesional curettage of atypical cartilaginous tumors.Journal of orthopaedic surgery and research · 2023Article
- Active surveillance of atypical cartilaginous tumours of bone: short term quality of life measurements.Journal of orthopaedic surgery and research · 2023Article
- Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings.Cancers · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSufficient data on outcome of patients with clinically and radiologically aggressive enchondromas and atypical cartilaginous tumors (ACT) is lacking. We therefore analyzed both conservatively and surgically treated patients with lesions, which were not distinguishable between benign enchondroma and low-grade malignant ACT based upon clinical and radiologic appearance.
methodsThe series included 228 consecutive cases with a follow-up > 24 months to assess radiological, histological, and clinical outcome including recurrences and complications. Pain, satisfaction, functional limitations, and the musculoskeletal tumor society (MSTS) score were evaluated to judge both function and emotional acceptance at final follow-up.
resultsFollow-up took place at a mean of 82 (median 75) months. The 228 patients all had comparable clinical and radiological findings. Of these, 153 patients were treated conservatively, while the other 75 patients underwent intralesional curettage. Besides clinical and radiological aggressiveness, most lesions were histologically judged as benign enchondromas. 9 cases were determined to be ACT, while the remaining 7 cases had indeterminate histology. After surgery, three patients developed a recurrence, and a further seven had complications of which six were related to osteosynthesis. Both groups had excellent and almost equal MSTS scores of 96 and 97%, respectively, but significantly less functional limitations were found in the non-surgery group. Further sub-analyses were performed to reduce selection bias. Sub-analysis of histologically diagnosed enchondromas in the surgery group found more pain, less function, and worse MSTS score compared to the non-surgery group. Sub-analysis of smaller lesions (< 4.4 cm) did not show significant differences. In contrast, larger lesions displayed significantly worse results after surgery compared to conservative treatment (enchondromas > 4.4 cm: MSTS score: 94.0% versus 97.3%, p = 0.007; pain 2.3 versus 0.8, p = 0.001). The majority of lesions treated surgically was filled with polymethylmethacrylate bone-cement, while the remainder was filled with cancellous-bone, without significant difference in clinical outcome.
conclusionFeasibility of intralesional curettage strategies for symptomatic benign to low-grade malignant chondrogenic tumors was supported. Surgery, however, did not prove superior compared to conservative clinical and radiological observation. Due to the low risk of transformation into higher-grade tumors and better functional results, more lesions might just be observed if continuous follow-up is assured.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.